Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Ishita Drugs & Industries Ltd (NSE: ISHITADR), ISIN INE806D01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ISHITADR last traded at ₹71.00 (-8.96%), with a 52-week range of ₹66.00 to ₹90.85 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 50.04%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 21/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.